Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Cash Flows

v3.21.2
Condensed Statement of Cash Flows - USD ($)
 3 Months Ended 7 Months Ended
Sep. 30, 2021
Sep. 30, 2021
Cash Flows From Operating Activities:    
Net income $ 3,374,061 $ 3,351,666
Adjustments to reconcile net income to net cash used in operating activities:    
Investment income earned on treasury securities held in the Trust Account (1,665) (1,665)
Costs associated with warrant liabilities 735,630 735,630
Gain on change in fair value of derivative liabilities (10,138,000) (10,138,000)
Share-based compensation   5,761,500
Changes in operating assets and liabilities:    
Prepaid expenses   (404,384)
Accounts payable and accrued expenses   91,309
Net Cash Used In Operating Activities   (603,944)
Cash Flows From Investing Activities:    
Cash deposited into the Trust Account   (169,000,000)
Net Cash Used In Investing Activities   (169,000,000)
Cash Flows From Financing Activities:    
Sale of Units in the Initial Public Offering, net of underwriting discount   165,620,000
Sale of Private Placement Warrants to the Sponsor   6,380,000
Payment of offering costs   (660,108)
Net Cash Provided By Financing Activities   171,339,892
Net change in cash and cash equivalents   1,735,948
Cash and cash equivalents at beginning of period   0
Cash and cash equivalents at end of period $ 1,735,948 1,735,948
Supplemental disclosure of non-cash financing activities:    
Initial classification of fair value of warrants   19,035,000
Deferred underwriting compensation charged to additional paid-in capital in connection with the Initial Public Offering   5,915,000
Formation and offering costs paid by Sponsor in exchange for Class B ordinary shares   25,000
Formation and operating costs paid by related party   73,297
Measurement adjustment of Class A ordinary shares to redemption value   $ 169,000,000